Shares of SMS Pharmaceuticals climbed 11.8 percent in
early trade Monday on getting approval from the US health regulator for one its
unit in Andhra Pradesh. "SMS has received approval from the US Food and
Drug Administration (USFDA) for manufacturing facility (unit 7) located at
Kandivalasa village, Pusapatirega Mandal, Vizianagaram distict, Andhra
Pradesh," says the Telangana-based pharma company in its filing. The US
health regulator had conducted inspection of this plant in third week of April.
At 09:31 hours IST, the scrip of SMS Pharmaceuticals was quoting at Rs 131.50,
up Rs 8.50, or 6.91 percent on the BSE.
Post A Comment:
0 comments: